Analysts Shift Tone on Charter Hall Shares Following Earnings

Charter Hall shares fell back 1.89% to A$20.23 on Tuesday, with the third consecutive earnings upgrade prompting a notable shift in broker sentiment, with JPMorgan abandoning its bearish stance alongside two other PT raises.

The Charter Hall share price closed out at A$20.23, extending the year-to-date decline to 17.23% despite a series of positive earnings revisions that have lifted FY26 operating earnings per share guidance to 103 cent, a roughly 26-27% increase on FY25. The stock now trades at a significant discount to broker targets, with the three-firm consensus sitting around A$22.85, implying potential upside of more than 13% from current levels.

The share price weakness stands in stark contrast to the company’s operational momentum, creating what some analysts describe a potential valuation disconnect. Whilst JPMorgan are no longer bearish, their price target reflects only a modest potential upside from here, with the adjustment coming more due to share price depreciation and valuation.

The Guidance

Charter Hall’s latest guidance update confirmed the company is experiencing unprecedented equity inflows across its institutional and retail platforms, with deployment velocity reaching levels not seen in the firm’s three-decade operating history. The funds management platform has successfully raised and deployed capital at record pace, building a pipeline of fee-earning assets that analysts expect will drive earnings acceleration through FY27.

The FY26 operating EPS guidance of 103 cents represents approximately a 3% upgrade from prior expectations, marking the third time in recent quarters that management has lifted its earnings outlook. This track record of “under-promise, over-deliver” has resonated with analysts who previously questioned the sustainability of the growth trajectory.

Management’s commentary emphasised the structural nature of the inflows, with capital coming from both existing and new investors seeking exposure to Australian commercial property through Charter Hall’s diversified platform. The deployment of this capital into transactions is already underway, with the annualised impact of current acquisitions expected to flow through earnings primarily in FY27 rather than the current financial year.

Analysts Shift

JPMorgan’s upgrade from Underweight to Neutral, while maintaining its A$21.00 price target, represents perhaps the most significant shift.

The firm acknowledged that Charter Hall’s consistent execution and the material de-rating in the share price year-to-date have narrowed the downside case that underpinned its previous bearish stance. The upgrade removes a structural seller from the market and signals improving risk-reward balance, even if JPMorgan stops short of recommending outright accumulation.

UBS maintained its Buy rating and nudged its target price from A$24.50 to A$24.75, explicitly lifting earnings forecasts from FY27 onward to reflect accelerating institutional and retail flows. The firm argued that strong growth justifies current valuation levels, positioning Charter Hall as an attractive entry point on a growth-adjusted basis when compared to the stock’s own 10-year valuation averages. This view suggests that despite the year-to-date decline, the market may be underappreciating the medium-term earnings power being built through current deployment activity.

Jarden retained its Neutral rating while increasing its target from A$22.59 to A$22.79, acknowledging that capital raising and deployment velocity have reached unprecedented levels. However, the firm cautioned that scope for FY26 outperformance appears limited given how much positive news is already reflected in the upgraded guidance. Jarden’s analysis suggests that FY27 will be the critical inflection year, with growth coming from the annualised impact of assets being acquired today, which should offset any risks from moderating transaction activity in the broader property market.

Valuation

The divergence between operational momentum and share price performance has created a debate around valuation. UBS’s growth-adjusted analysis suggests Charter Hall is trading below its historical averages when normalising for the current earnings trajectory, supporting the view that the market is applying excessive caution to a business demonstrating strong execution.

However, the two Neutral ratings from JPMorgan and Jarden highlight legitimate concerns about timing and near-term catalysts. With much of the earnings acceleration weighted toward FY27, investors face a potential 12-18 month wait for the deployment activity to translate into materially higher profits. This creates vulnerability if macroeconomic conditions deteriorate or if transaction volumes in Australian commercial property weaken before the earnings growth materialises.

The interest rate environment remains a key variable. While the Reserve Bank of Australia’s monetary policy stance has stabilised, any unexpected tightening or renewed pressure on property valuations could challenge both the deployment thesis and the multiple expansion that bulls are anticipating.

What Next for CHC

For bulls, the combination of three earnings upgrades, record inflows, and a share price trading at or below most broker targets creates an attractive opportunity, particularly for investors with a 12–24 month time horizon who can look through near-term volatility. The structural advantages of Charter Hall’s platform remain intact and are being validated by the operational performance.

For bears, the concentration of growth expectations in FY27 rather than FY26 creates execution risk and leaves the stock vulnerable to multiple compression if macro conditions deteriorate or if transaction volumes disappoint. The fact that two of three major brokers remain at Neutral despite acknowledging strong execution suggests the risk-reward at current levels is balanced rather than compelling, with patience required before the deployment activity translates into sustained earnings growth.